Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
National Health Investors, Inc.
NHI
NYSE·Real Estate·REIT - Healthcare Facilities·Mkt cap $3.7B
$77.10
▲ +0.72%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$67.94 - $91.38
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 8.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Established relationships with quality healthcare operators and proven underwriting expertise
- Diversified portfolio across senior housing types and medical facilities reducing concentration risk
- REIT structure providing tax-efficient dividend income and capital appreciation potential
- Experienced management team with deep healthcare real estate knowledge since 1991
- Multiple financing strategies (sale-leaseback, joint ventures, mortgages) enabling flexible deal structures
Bear Case
1 risk
- Low volatility (beta 0.5).
Growth
Revenue decline expected
Aging U.S. population with increasing demand for senior housing and healthcare services
Value
Undervalued - trading well below Healthcare REITs peers
Momentum
Weak
-8.0% over 3m
Quality
Excellent
Excellent business quality
Dividend
Solid
4.81% yield
Smart-money signal
Who's buying NHI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 5, 2026
MAY 4, 2026
Reported EPS of $0.83 vs $0.92 consensus (-10.0% surprise). Revenue of $73.2M vs $70.2M expected (+4.2%).
EPS surprise · last 4Q
0 of 1 beats
Q2 26
-10.0%
Next: Aug 5, 2026
Revenue trend · last 8Q
—
—
+8%
+10%
+7%
+8%
+24%
+30%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$85.0M
$82.9M
$85.8M
$89.3M
$90.7M
$89.8M
$106.5M
$115.9M
Margins · last 8Q
Gross
—
Operating
—
Profit
34.6%
Wall Street consensus
4 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: Deutsche Bank · Jun 25, 2026